Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 2797663)

Published in World J Gastroenterol on December 28, 2009

Authors

Kajsa Kajander1, Eveliina Myllyluoma, Sinikka Kyrönpalo, Martin Rasmussen, Pentti Sipponen, Ismo Mattila, Tuulikki Seppänen-Laakso, Heikki Vapaatalo, Matej Oresic, Riitta Korpela

Author Affiliations

1: Institute of Biomedicine, Pharmacology, University of Helsinki, PO Box 63, FI-00014, Helsinki, Finland.

Articles cited by this

Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64

Functional bowel disorders. Gastroenterology (2006) 20.72

Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63

AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76

Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75

Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology (2002) 5.50

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04

Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res (2005) 4.24

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04

Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics (2005) 3.21

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology (2002) 3.11

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99

Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res (2006) 2.68

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology (2007) 2.63

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study. PLoS One (2007) 2.38

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology (2006) 2.28

Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil (2000) 2.16

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol (2007) 2.01

Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res (2007) 1.99

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut (2006) 1.60

Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn (2006) 1.41

Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit (2005) 1.37

Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil (2007) 1.33

Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med (2001) 1.28

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics (2006) 1.19

Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res (2006) 1.16

Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut (1994) 1.11

Monitoring the health to disease continuum with global metabolic profiling and systems biology. Pharmacogenomics (2006) 1.11

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol (2007) 1.05

Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats. Acta Physiol Scand (2004) 1.00

Lysophosphatidylcholine increases rat ileal permeability to macromolecules. Gut (1985) 0.99

Lipid mediators of sensitivity in sensory neurons. Trends Pharmacol Sci (2005) 0.94

The creatine kinase system in smooth muscle. Mol Cell Biochem (1995) 0.93

Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice. Cell Immunol (2007) 0.89

IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells. Mediators Inflamm (2002) 0.88

Lysophosphatidylcholine potentiates the increase in mucosal permeability after small-intestinal ischaemia. Scand J Gastroenterol (1986) 0.84

Phospholipase A2 in serum and colonic mucosa in ulcerative colitis. Scand J Clin Lab Invest (1999) 0.80

Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism. Pediatr Surg Int (2002) 0.80

Lipid mediators regulating pain sensitivity. Prostaglandins Other Lipid Mediat (2005) 0.79

Lysophosphatidylcholine and taurodeoxycholate increase stomach permeability to different-sized molecules. Scand J Gastroenterol (1986) 0.78

Articles by these authors

MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics (2010) 5.77

MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics (2006) 5.38

Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci U S A (2009) 4.61

Pathways to the analysis of microarray data. Trends Biotechnol (2005) 3.88

Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev (2009) 3.64

Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics (2005) 3.21

Data processing for mass spectrometry-based metabolomics. J Chromatogr A (2007) 3.21

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99

PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet (2007) 2.91

Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol (2006) 2.86

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med (2008) 2.79

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med (2010) 2.76

The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2009) 2.59

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study. PLoS One (2007) 2.38

A functional genomics approach toward the understanding of secondary metabolism in plant cells. Proc Natl Acad Sci U S A (2003) 2.37

Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res (2008) 2.15

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes (2007) 2.08

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res (2011) 2.07

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol (2007) 2.01

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS One (2006) 2.01

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol (2004) 1.96

Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med (2008) 1.94

Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol (2003) 1.92

Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J Lipid Res (2008) 1.91

Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol (2011) 1.89

Human gut microbes impact host serum metabolome and insulin sensitivity. Nature (2016) 1.85

Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet (2011) 1.80

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol (2009) 1.80

Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet (2010) 1.78

The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes (2005) 1.76

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics (2008) 1.74

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes (2011) 1.73

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol (2005) 1.67

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol (2006) 1.66

Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process. Bioinformatics (2007) 1.54

Gene-to-metabolite networks for terpenoid indole alkaloid biosynthesis in Catharanthus roseus cells. Proc Natl Acad Sci U S A (2006) 1.53

Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epithelium. Scand J Gastroenterol (2008) 1.53

Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics (2007) 1.50

A follow-up study of nutrient intake, nutritional status, and growth in infants with cow milk allergy fed either a soy formula or an extensively hydrolyzed whey formula. Am J Clin Nutr (2005) 1.49

Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data. Radiology (2008) 1.48

Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia. Cardiovasc Res (2011) 1.46

Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer. J Clin Gastroenterol (2013) 1.46

A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr (2003) 1.45

Angiotensin II and vascular inflammation. Med Sci Monit (2005) 1.44

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol (2005) 1.40

Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring) (2009) 1.39

Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol (2006) 1.38

Informatics and computational strategies for the study of lipids. Mol Biosyst (2007) 1.37

Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr (2010) 1.33

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS (2003) 1.33

Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study. PLoS One (2008) 1.31

Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol (2005) 1.29

Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity (2010) 1.28

Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol (2011) 1.28

Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Anal Chem (2011) 1.24

Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes (2008) 1.24

Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol (2008) 1.21

Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow's milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. J Pediatr (2002) 1.21

Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr (2005) 1.21

Diet promotes sleep duration and quality. Nutr Res (2012) 1.20

Integrated multilaboratory systems biology reveals differences in protein metabolism between two reference yeast strains. Nat Commun (2010) 1.18

Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18

Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol (2010) 1.17

Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens (2005) 1.17

Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet (2010) 1.17

Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes (2011) 1.14

Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol (2008) 1.14

Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr (2010) 1.13

Bioinformatics and computational methods for lipidomics. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.13

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol (2009) 1.13

Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res (2012) 1.13

ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan. Diabetes (2009) 1.12

Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol (2008) 1.11

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res (2010) 1.10

Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One (2011) 1.08

Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol (2008) 1.08